“Head and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s740. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/4098.